Gushen Antai pill to improve IVF ongoing pregnancy rates
Part of Women’s health & pregnancy clinical trials.
This trial studies whether a traditional Chinese medicine pill (Gushen Antai) can improve the chance of an IVF pregnancy that continues (“ongoing pregnancy rate”) and assess its safety. It’s for people starting their first IVF/ICSI cycle with normal ovarian function reserve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your egg levels are in a normal range: AFC between 5 and 15 and AMH between 1.2 and 3.5.
- You have regular periods (about every 21–35 days) and normal ovulation.
- You are doing your first IVF or ICSI cycle (not a later treatment cycle).
- There is at least one embryo or blastocyst ready for transfer.
- You are under 43 years old and your BMI is under 28.
- You are using a standard IVF approach (not freeze-all, natural-cycle, or mild stimulation), and you do not have certain major fertility-related diagnoses (like PCOS or specific genetic/planned testing procedures).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.
This trial tests whether a traditional Chinese medicine pill called Zishen Yutai can help with repeated implantation failure—when embryos fail to implant during in vitro fertilization (IVF). You would take this pill before a frozen embryo transfer to see if it improves your chances of pregnancy.
This trial studies whether adding acupuncture during embryo transfer and hormone treatment can improve pregnancy outcomes for women who have had repeat IVF implantation failures with no known cause. It may help your chance of clinical pregnancy when you transfer good-quality frozen embryos.
This study tests whether ShouTai pills can improve the number or quality of eggs in women with decreased ovarian reserve who are planning IVF. It combines traditional Chinese medicine with standard IVF care.
This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.
This trial tests whether a special herbal formula, given before an IVF cycle, can improve pregnancy success in women with diminished ovarian reserve. It is for women who are aged 22 to 39, have low egg supply, and have a Traditional Chinese Medicine diagnosis of Kidney Deficiency.
Hear when a new Infertility, Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.